$GTCH
GBT Technologies Inc. Stock $gtch

$gtch Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000173112224000657 Filed on April 19, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$0.00
YoY Change		-100.0%
Cost Of Revenue		$0.00
YoY Change		-100.0%
Gross Profit		$0.00
YoY Change		-100.0%
Gross Profit Margin
Selling, General & Admin	$52.96K	$652.7K	$744.7K
YoY Change	-72.22%	-1.38%	-47.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$176.1K	$652.7K	$1.740M
YoY Change	-47.36%	6.67%	-45.24%
Operating Profit	-$176.1K	-$652.7K	-$1.740M
YoY Change	-49.96%	15.83%	-37.81%
Interest Expense		-$1.598M	$2.582M
YoY Change		-146.19%	166.25%
% of Operating Profit
Other Income/Expense, Net	$1.223M	$17.84K	-$15.99M
YoY Change	-112.78%	-89.64%	-296.9%
Pretax Income	$1.046M	-$2.192M	-$17.73M
YoY Change	-110.55%	-171.45%	-433.09%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$1.048M	-$2.137M	-$17.76M
YoY Change	-110.58%	-169.65%	-433.6%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	16.81B shares	8.654B shares	4.462B shares
Diluted Shares Outstanding	69.41B shares		27.79B shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.01K	$31.74K	$31.74K
YoY Change	-38.12%	-74.16%	-74.16%
Cash & Equivalents	$6.131K	$529.00
Short-Term Investments	$28.88K	$31.14K	$31.14K
Other Short-Term Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$81.26K	$77.99K	$77.99K
YoY Change	-77.09%	-78.96%	-78.96%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$81.26K	$77.99K	$77.99K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$81.26K	$77.99K	$77.99K
YoY Change	-77.09%	-78.96%	-78.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$775.0K	$774.0K	$2.542M
YoY Change	-24.68%	-49.44%	66.04%
Accrued Expenses	$0.00	$499.5K	$8.689M
YoY Change	-100.0%	-66.99%	-1.26%
Deferred Revenue		$0.00
YoY Change		-100.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.973M	$6.513M	$6.513M
YoY Change	-13.87%	-2.73%	-2.73%
Total Short-Term Liabilities	$22.40M	$31.86M	$31.86M
YoY Change	-27.85%	68.63%	68.63%
LONG-TERM LIABILITIES
Long-Term Debt	$328.8K	$328.8K	$328.8K
YoY Change	5.79%	6.44%	6.44%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$328.7K	$328.7K	$328.8K
YoY Change	5.79%	6.44%	6.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.40M	$31.86M	$31.86M
Total Long-Term Liabilities	$328.7K	$328.7K	$328.8K
Total Liabilities	$22.73M	$32.19M	$31.15M
YoY Change	-27.52%	67.63%	62.24%
SHAREHOLDERS EQUITY
Retained Earnings	-$307.8M	-$316.0M
YoY Change	-2.25%	5.59%
Common Stock	$168.1K	$102.5K
YoY Change	202.9%	567.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$11.06K	$11.06K
YoY Change	-98.28%	-98.28%
Treasury Stock Shares
Shareholders Equity	-$21.60M	-$31.07M	-$31.07M
YoY Change
Total Liabilities & Shareholders Equity	$81.26K	$77.99K	$77.99K
YoY Change	-77.09%	-78.96%	-78.96%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$1.048M	-$2.137M	-$17.76M
YoY Change	-110.58%	-169.65%	-433.6%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$22.46K	$21.16K	-$51.34K
YoY Change	-121.48%	-104.49%	-62.87%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-16.50K	-21.22K	$38.81K
YoY Change	-118.42%	-140.03%	-89.36%
NET CHANGE
Cash From Operating Activities	22.46K	21.16K	-$51.34K
Cash From Investing Activities		0.000
Cash From Financing Activities	-16.50K	-21.22K	$38.81K
Net Change In Cash	5.960K	-60.00	-$12.53K
YoY Change	-139.76%	-99.99%	-74.15%
FREE CASH FLOW
Cash From Operating Activities	$22.46K	$21.16K	-$51.34K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001471781
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets		usd
CY2023Q4	us-gaap	Unearned Premiums UnearnedPremiums		usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q4	GTCH	Due To Related Party Current DueToRelatedPartyCurrent		usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2022Q4	GTCH	Shares To Be Cancelled SharesToBeCancelled		usd
CY2023	GTCH	Sales Sales		usd
CY2022	GTCH	Sales Sales		usd
CY2023	GTCH	Revenue From Related Party RevenueFromRelatedParty		usd
CY2023	us-gaap	Revenues Revenues		usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2023	us-gaap	Gross Profit GrossProfit		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	GTCH	Gain On Rjw Settlement GainOnRjwSettlement		usd
CY2022	GTCH	Gain On Loss Of Control GainOnLossOfControl		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	GTCH	Common Stock Issued For Jv Tokenize CommonStockIssuedForJvTokenize		usd
CY2022	GTCH	Cancellation Of Shares CancellationOfShares		usd
CY2022	GTCH	Equity Method Investment Meta EquityMethodInvestmentMeta		usd
CY2023	GTCH	Shares Issued To Tokenize SharesIssuedToTokenize		usd
CY2023	GTCH	Reclassification Of Shares To Be Issues ReclassificationOfSharesToBeIssues		usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	GTCH	Gain On Debt Settlement GainOnDebtSettlement		usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023	GTCH	Increase Decrease In Inventory In Transit IncreaseDecreaseInInventoryInTransit		usd
CY2022	GTCH	Increase Decrease In Inventory In Transit IncreaseDecreaseInInventoryInTransit		usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities		usd
CY2023	GTCH	Investment To Gtx InvestmentToGtx		usd
CY2023	GTCH	Investment To Tghi InvestmentToTghi		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	GTCH	Issuance Of Note Receivable IssuanceOfNoteReceivable		usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Interest Paid InterestPaid		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	GTCH	Share Issuance For Jv Metaverse ShareIssuanceForJvMetaverse		usd
CY2023	GTCH	Share Issuance For Jv Tokenize ShareIssuanceForJvTokenize		usd
CY2023Q4	GTCH	Convertible Notes Payable Longterm Portion ConvertibleNotesPayableLongtermPortion		usd
CY2022Q4	GTCH	Convertible Notes Payable Longterm Portion ConvertibleNotesPayableLongtermPortion		usd
CY2023Q4	GTCH	Unamortized Debt Discount At Convertible Note Payable UnamortizedDebtDiscountAtConvertibleNotePayable		usd
CY2022Q4	GTCH	Unamortized Debt Discount At Convertible Note Payable UnamortizedDebtDiscountAtConvertibleNotePayable		usd
CY2023Q4	GTCH	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	GTCH	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	GTCH	Debt Instruments Unamortized Discount Current DebtInstrumentsUnamortizedDiscountCurrent		usd
CY2023Q4	GTCH	Debt Instruments Unamortized Discount Currents DebtInstrumentsUnamortizedDiscountCurrents		usd
CY2022Q4	GTCH	Debt Instruments Unamortized Discount Currents DebtInstrumentsUnamortizedDiscountCurrents		usd
CY2023Q4	GTCH	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	GTCH	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate		pure
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate		pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	West Hollywood
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90069
CY2023	dei	City Area Code CityAreaCode	888
CY2023	dei	Local Phone Number LocalPhoneNumber	685-7336
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	976950	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16813229180	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	5081
CY2023	dei	Auditor Name AuditorName	M.S. Madhava Rao
CY2023	dei	Auditor Location AuditorLocation	Bengaluru, India
CY2023Q4	us-gaap	Cash Cash	592	usd
CY2022Q4	us-gaap	Cash Cash	13058	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12500	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	46250	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	198475	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	31206	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	16198	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	130394	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	77985	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	370625	usd
CY2023Q4	us-gaap	Assets Assets	77985	usd
CY2022Q4	us-gaap	Assets Assets	370625	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5372846	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4564098	usd
CY2023Q4	GTCH	Accounts Payable Related Party AccountsPayableRelatedParty	1767710	usd
CY2022Q4	GTCH	Accounts Payable Related Party AccountsPayableRelatedParty	1539802	usd
CY2023Q4	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	us-gaap	Unearned Premiums UnearnedPremiums	48921	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	41444	usd
CY2023Q4	GTCH	Debt Instrument Unamortized Discount Currents DebtInstrumentUnamortizedDiscountCurrents	66512	usd
CY2022Q4	GTCH	Debt Instrument Unamortized Discount Currents DebtInstrumentUnamortizedDiscountCurrents	189060	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5665017	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	6397727	usd
CY2023Q4	GTCH	Debt Instrument Payable To Related Party Unamortized Discount Current DebtInstrumentPayableToRelatedPartyUnamortizedDiscountCurrent	0	usd
CY2022Q4	GTCH	Debt Instrument Payable To Related Party Unamortized Discount Current DebtInstrumentPayableToRelatedPartyUnamortizedDiscountCurrent	0	usd
CY2023Q4	GTCH	Convertible Note Payable ConvertibleNotePayable	661395	usd
CY2022Q4	GTCH	Convertible Note Payable ConvertibleNotePayable	116605	usd
CY2023Q4	GTCH	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	4077	usd
CY2022Q4	GTCH	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	0	usd
CY2023Q4	GTCH	Note Payable Current NotePayableCurrent	46532	usd
CY2022Q4	GTCH	Note Payable Current NotePayableCurrent	41137	usd
CY2023Q4	GTCH	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2022Q4	GTCH	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2022Q4	GTCH	Due To Related Party Current DueToRelatedPartyCurrent	27375	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14116062	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1714143	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	171362	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31859619	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18892671	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	328748	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	308863	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	328748	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	308863	usd
CY2023Q4	us-gaap	Liabilities Liabilities	32188367	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19201534	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10253695062	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10253695062	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1535593440	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1535593440	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	102538	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	15356	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1040	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11059	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	643059	usd
CY2023Q4	GTCH	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2022Q4	GTCH	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2023Q4	GTCH	Shares To Be Cancelled SharesToBeCancelled	-632000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	293069829	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	288664858	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-315993294	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-298232829	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-31074133	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-17805821	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1036249	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-1025088	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-32110382	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-18830909	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77985	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	370625	usd
CY2022	GTCH	Revenue From Related Party RevenueFromRelatedParty	90000	usd
CY2022	us-gaap	Revenues Revenues	90000	usd
CY2022	us-gaap	Gross Profit GrossProfit	90000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	507261	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	701270	usd
CY2023	us-gaap	Marketing Expense MarketingExpense	237428	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	360335	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	995532	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1785908	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1740221	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2847513	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1740221	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2757513	usd
CY2023	GTCH	Amortization Of Financing Cost AmortizationOfFinancingCost	322933	usd
CY2022	GTCH	Amortization Of Financing Cost AmortizationOfFinancingCost	442247	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-13759482	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	6594370	usd
CY2023	us-gaap	Interest Expense InterestExpense	2581658	usd
CY2022	us-gaap	Interest Expense InterestExpense	969473	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	315297	usd
CY2022	GTCH	Gain On Rjw Settlement GainOnRjwSettlement	3012355	usd
CY2023	GTCH	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	10992	usd
CY2022	GTCH	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	310462	usd
CY2023	GTCH	Gain On Loss Of Control GainOnLossOfControl	79354	usd
CY2023	us-gaap	Other Income OtherIncome	287394	usd
CY2022	us-gaap	Other Income OtherIncome	237803	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15993020	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8122346	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17733241	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5364833	usd
CY2023	GTCH	Profit Loss From Continuing Operations ProfitLossFromContinuingOperations	-17733241	usd
CY2022	GTCH	Profit Loss From Continuing Operations ProfitLossFromContinuingOperations	5364833	usd
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-38385	usd
CY2022	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-40977	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-17771626	usd
CY2022	us-gaap	Profit Loss ProfitLoss	5323856	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6348944	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4462434507	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	696686911	shares
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11161	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1025088	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17760465	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27786282982	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4646981551	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-28761980	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2165460	usd
CY2022	GTCH	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	2209888	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	231867	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5323856	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-18830909	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1684671	usd
CY2023	GTCH	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	2727482	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17771626	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-32110382	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-17771626	usd
CY2022	us-gaap	Profit Loss ProfitLoss	5323856	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	322933	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	442247	usd
CY2023	GTCH	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	13759482	usd
CY2022	GTCH	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-6594370	usd
CY2023	GTCH	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts	1462446	usd
CY2022	GTCH	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts	34175	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	80000	usd
CY2023	GTCH	Change In Fair Value Of Marketable Security ChangeInFairValueOfMarketableSecurity	10992	usd
CY2022	GTCH	Change In Fair Value Of Marketable Security ChangeInFairValueOfMarketableSecurity	308802	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	315297	usd
CY2022	GTCH	Gain On Debt Settlement GainOnDebtSettlement	3012633	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-152225	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3741525	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-12500	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	12500	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-74921	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-200463	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-41444	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-8556	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2123460	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-253957	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	227908	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-51342	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-231874	usd
CY2022	GTCH	Investment To Gtx InvestmentToGtx	150000	usd
CY2022	GTCH	Investment To Tghi InvestmentToTghi	125000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-275000	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	92150	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	300000	usd
CY2022	GTCH	Issuance Of Note Receivable IssuanceOfNoteReceivable	190000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	231867	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	27375	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	694225	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	39043	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	39043	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	756227	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	79070	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	92150	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38812	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	364826	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12529	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-142048	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13058	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155106	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	529	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13058	usd
CY2023	GTCH	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	35576	usd
CY2022	GTCH	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	325916	usd
CY2023	GTCH	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	2727481	usd
CY2022	GTCH	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	2209887	usd
CY2023	GTCH	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	1684671	usd
CY2022	GTCH	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	2165464	usd
CY2022	GTCH	Share Issuance For Jv Metaverse ShareIssuanceForJvMetaverse	5000	usd
CY2022	GTCH	Share Issuance For Jv Tokenize ShareIssuanceForJvTokenize	1500	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 50
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Unit Authorized CommonUnitAuthorized	10000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-315993294	usd
CY2023	GTCH	Working Capital Deficit WorkingCapitalDeficit	31781634	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zDXlTekxji2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_865_zDOBDTMC7xha">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p>
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	0	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	375000	usd
CY2022Q1	us-gaap	Escrow Deposit EscrowDeposit	19694	usd
CY2023	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	100000	usd
CY2021Q3	GTCH	Stockholders Equitys StockholdersEquitys	50000	usd
CY2022Q2	GTCH	Stockholders Equitys StockholdersEquitys	50000	usd
CY2023	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zahSbf9czHql" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_861_zA1UdtYMRKtg">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2022 and 2021, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q4	GTCH	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	1714143	usd
CY2023Q4	GTCH	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	14116062	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zvd7fypfOMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_zlAWyiEKADPd">Reclassification</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective July 1, 2023 the Company terminated its joint venture revenue sharing (“Termination Agreement”) with Mahaser LTD (“Mahaser”). Until June 30, 2023, the Company’s variable interests in Mahaser obligate the Company to absorb deficits and provide it with the right to receive benefits that could potentially be significant to Mahaser. The Company evaluated for the period ended on June 30, 2023, whether it has a variable interest in Mahaser, whether Mahaser is a VIE and whether the Company has a controlling financial interest in Mahaser. The Company concluded that it has variable interests in Mahaser on the basis of GBT has 100% control over the JV/revenue sharing, and as such should consolidate the JV into its books and records as it assigned 100% financial responsibility. Mahaser’s equity at risk, as defined by GAAP, is considered to be insufficient to finance its activities without additional support, and, therefore, Mahaser is considered a VIE. As termination Agreement took place during the reporting period, the financial been classified to disclose this operation as discontinued operation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4	GTCH	Unearned Revenue UnearnedRevenue	0	usd
CY2022Q4	GTCH	Unearned Revenue UnearnedRevenue	48921	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	41444	usd
CY2022Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	200000	usd
CY2020Q1	GTCH	Services Payable ServicesPayable	33333	usd
CY2020Q1	GTCH	Impairment Charge ImpairmentCharge	5500000	usd
CY2021Q4	GTCH	Impairment Charge ImpairmentCharge	15400000	usd
CY2023Q4	us-gaap	Investments Investments	0	usd
CY2022Q4	us-gaap	Investments Investments	0	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	6397727	usd
CY2023Q4	GTCH	Less Current Portion LessCurrentPortion	-5665017	usd
CY2022Q4	GTCH	Less Current Portion LessCurrentPortion	-6397727	usd
CY2021	GTCH	Charge Related To Modification Of Debt ChargeRelatedToModificationOfDebt	13777480	usd
CY2023	GTCH	Convertible Note Payable Description ConvertibleNotePayableDescription	IGOR 1 converted $1,182,535 of the convertible note into 6,309,235,294 shares of the Company’s common stock.
CY2023Q4	GTCH	Outstanding Balance OutstandingBalance	1486	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	74974742666	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3949360301	shares
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	773974	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	876266	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	499492	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	543887	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	4099380	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3143945	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	5372846	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4564098	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	48921	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	5708756	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	6586788	usd
CY2023Q4	GTCH	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-43739	usd
CY2022Q4	GTCH	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-189060	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	5665017	usd
CY2023Q4	GTCH	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	661395	usd
CY2022Q4	GTCH	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	116605	usd
CY2023Q4	GTCH	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	661395	usd
CY2022Q4	GTCH	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	116605	usd
CY2023Q4	GTCH	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-661395	usd
CY2022Q4	GTCH	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-116605	usd
CY2023Q4	GTCH	Total Notes Payables TotalNotesPayables	377546	usd
CY2022Q4	GTCH	Total Notes Payables TotalNotesPayables	350000	usd
CY2023Q4	GTCH	Debt Instruments Unamortized Discount Current DebtInstrumentsUnamortizedDiscountCurrent	-2265	usd
CY2023Q4	GTCH	Note Payables NotePayables	375281	usd
CY2022Q4	GTCH	Note Payables NotePayables	350000	usd
CY2023Q4	GTCH	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	-46533	usd
CY2022Q4	GTCH	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	-41137	usd
CY2023Q4	GTCH	Long Term Note Payables LongTermNotePayables	328748	usd
CY2022Q4	GTCH	Long Term Note Payables LongTermNotePayables	308863	usd
CY2023	GTCH	Schedule Of Note Payable Related Parties Table Textblock ScheduleOfNotePayableRelatedPartiesTableTextblock	<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zsYByikirFC9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B5_zpGTBXqt6l5a" style="display: none">Schedule of notes payable related parties</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td> </td> <td colspan="3" style="text-align: center">December 31,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Alpha Eda note payable</td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_z6IUorFFsLqh" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20221231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total notes payable, related party</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--TotalNotesPayableRelatedParties_pp0p0_c20231231_zFcHgMdHNKE2" style="text-align: right" title="Total notes payable, related party">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--TotalNotesPayableRelatedParties_iI_pp0p0_c20221231_zSE2geMbjAm" style="text-align: right" title="Total notes payable, related party">140,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_pp0p0_c20231231_zVDxNFkmxFG4" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount"><span style="-sec-ix-hidden: xdx2ixbrl1619">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_pp0p0_c20221231_zXcTmrIjTa5h" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount"><span style="-sec-ix-hidden: xdx2ixbrl1621">—</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--NotesPayableRelatedParties_iI_pp0p0_c20231231_zjKwuWsTubac" style="text-align: right" title="Notes payable, net, related party">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--NotesPayableRelatedParties_c20221231_pp0p0" style="text-align: right" title="Notes payable, net, related party">140,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CurrentPortionOfNotePayableRelatedParties_iI_pp0p0_c20231231_zFfvUL6eAom7" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--CurrentPortionOfNotePayableRelatedParties_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--NotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0_c20231231_zwndP6DbV5d" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="-sec-ix-hidden: xdx2ixbrl1631">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="-sec-ix-hidden: xdx2ixbrl1633">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2023Q4	GTCH	Total Notes Payable Related Parties TotalNotesPayableRelatedParties	140000	usd
CY2022Q4	GTCH	Total Notes Payable Related Parties TotalNotesPayableRelatedParties	140000	usd
CY2023Q4	GTCH	Notes Payable Related Parties NotesPayableRelatedParties	140000	usd
CY2022Q4	GTCH	Notes Payable Related Parties NotesPayableRelatedParties	140000	usd
CY2023Q4	GTCH	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2022Q4	GTCH	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2023Q4	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.001
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.001
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1714143	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	1369920	usd
CY2023	GTCH	Fair Value Of Beneficial Conversion Feature Of Debt Converted FairValueOfBeneficialConversionFeatureOfDebtConverted	2727482	usd
CY2023	GTCH	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos	13759482	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14116062	usd
CY2022Q4	us-gaap	Share Price SharePrice	0.001
CY2023Q4	us-gaap	Share Price SharePrice	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
CY2023	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	8618101622	shares
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1632459	usd
CY2023	GTCH	Debt Conversion Converted Instrument Accrued Interest DebtConversionConvertedInstrumentAccruedInterest	52211	usd
CY2023Q4	GTCH	Treasury Shares Issued TreasurySharesIssued	8	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11059	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	70770	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	205.07
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y3M18D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	70370	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1595
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y7D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	400	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1595
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y7D
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10216110	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9182327	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10216110	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9182327	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10216110	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9182327	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	1072552	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	237089	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	31663196	usd
CY2023	GTCH	Income Tax Reconciliation Income Taxes Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxesExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3735296	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	GTCH	Income Tax Reconciliation Income Taxes Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxesExpenseBenefitAtFederalStatutoryIncomeTaxRate	1118010	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1422970	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.080	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	425908	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.080	pure
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	4083900	usd
CY2023	GTCH	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	-0.335	pure
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1784116	usd
CY2022	GTCH	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	-0.335	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1074366	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.045	pure
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	237089	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.045	pure
CY2023	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_809_eus-gaap--LossContingencyDisclosures_zSr8pHlLTX5i" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 19 - <span id="xdx_82E_zBC6WkiStfn6">Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>GBT Technologies, S.A.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $<span id="xdx_908_eus-gaap--Revenues_pp0p0_c20180913__20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zMIfdFVzBPud" title="Revenues">300,000</span> which is nonrefundable. The Company recognized the $<span id="xdx_909_eus-gaap--Revenues_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zrjcWjKwncbl" title="Revenues">300,000</span> as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $<span id="xdx_900_ecustom--PaymentForExpenses_pp0p0_c20180913__20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zC3Jn6cFSow3" title="Payment for expenses">5,000,000</span>. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $<span id="xdx_90E_eus-gaap--DeferredRevenue_iI_c20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zj4I99M5ZKYh" title="Unearned revenue">200,000</span> to the Company, which the parties have agreed will be applied toward the $<span id="xdx_90F_ecustom--DueToRelatedPartyFees_iI_pp0p0_c20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zpfh7J1ksU5f" title="Fees">5,000,000</span> fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stock Loan Receivable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_z39Exd8wYtZ7" title="Restricted shares">4,006</span> restricted shares of its common stock valued at $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zlBn5UILDHyh" title="Value of restricted shares">7,610,147</span> (based on the closing price on the grant date) for three years for an annual payment of $<span id="xdx_900_ecustom--AnnualPayment_iI_c20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zSptk1E5orEa" title="Annual payment">375,000</span> paid in quarterly installments of $<span id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPayment_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zwWswkh3A1Qe" title="Instalment paid">93,750</span>. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $<span id="xdx_90D_ecustom--DecreaseInCapital_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_z0iuKL6JPgH5" title="Decrease in capital">5,000,000</span>, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_z8jGO3fKKY27" title="Cancellation restricted shares">4,006</span> restricted shares to the Company for cancellation. The <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zJOdps87ZV77" title="Restricted shares">4,006</span> restricted shares have not yet been returned to the Company as of December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Metaverse Agreements</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 10, 2022, the Company, entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”). Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">market and distribute the Meta Portfolio throughout the world. The Company was required to contribute <span id="xdx_907_eus-gaap--SharesIssued_iI_c20220610__us-gaap--TypeOfArrangementAxis__custom--MetaverseAgreementsMember_zu566hiYtona" title="Share issued">500,000,000</span> shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its <span id="xdx_908_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20220610__us-gaap--TypeOfArrangementAxis__custom--MetaverseAgreementsMember_zbhq8faeEgrj" title="Ownership percentage">50</span>% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit. In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $<span id="xdx_901_ecustom--PaymentForServices_c20220609__20220610__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementsMember_zEQU4y95koCg" title="Payment for services">25,000</span> per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The closing of the Metaverse Agreement occurred on June 13, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $<span id="xdx_909_ecustom--PaymentForSettlement_c20230313__20230314__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zH4d6S2GG14h" title="Payment for settlement">5,000</span> to the Company as settlement payment and surrender their shares in Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 1, 2023, the Company engaged AlKhatib Consulting Group to provide exclusive representation services in connect with managing market partners, effective on February 1, 2023 for 24 consecutive months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Assets Sale - TREN</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned <span id="xdx_90A_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20230403__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zRqmPopL70r3" title="Ownership percentage">50</span>% by the Company, entered into an agreement to sell certain assets relating to a proprietary system and method named Avant-Ai to TREN. Avant-Ai is a text-generation, deep learning self-training model. In exchange for the assets, TREN is required to issue <span id="xdx_909_ecustom--NumberOfSharesReceived_iI_c20230403__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zhjCe2EdTfzj" title="Number of shares sold">26,000,000</span> common shares (“Shares”) to Seller. The Shares will be restricted under Rule 144 of the Securities Act of 1933, as amended, and Seller agreed to a lock-up period of nine months following closing. If TREN is unable to up-list to Nasdaq either through a business combination or otherwise within nine months of the closing, Seller may request that all transactions contemplated by the agreement be unwound.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 18, 2023, TREN changed its name to Avant Technologies, Inc. and its ticker symbol on OTC Markets was changed to AVAI.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Potential IP’s Sale</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 17, 2023, Bannix Acquisition Corp. (“Bannix”), EVIE Autonomous Group Ltd. (“EVIE”) and EVIE’s shareholders entered into a Business Combination Agreement pursuant to which Bannix agreed to acquire EVIE. In addition, Bannix agreed to acquire from GBT Technologies Inc. (the “Company” or “GBT”), the Apollo System which is intellectual property covered by patent application filed with the US Patent and Trademark Office. This patent application describes a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and moving objects. The Apollo system is based on radio waves and can detect an entity’s moving and stationary positions, enabling imaging technology to show these movements and positions on a screen in real time. This includes an AI technology that controls the radio waves transmission and analyzes the reflections. The goal is to integrate the Apollo System as an efficient driver monitoring system, detecting impaired or distracted drivers, providing audible and visual alerts (“the “Patents”). On August 8, 2023, Bannix entered into a Patent Purchase Agreement (“PPA”) with GBT Tokenize Corp. (“Tokenize”), which is <span id="xdx_902_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20230808__srt--OwnershipAxis__custom--TokenizeMember__us-gaap--TypeOfArrangementAxis__custom--PatentPurchaseAgreementMember_zgDdZuUsDZ4b" title="Ownership percentage">50</span>% owned by GBT, where GBT provided its consent, to acquire the entire right, title, and interest of the Patents. The closing date of the PPA will be immediately follow the closing of the acquisition of EVIE by Bannix. The Purchase Price is set at 5% of the consideration that Bannix is paying to the shareholders of EVIE. The Business Combination Agreement sets the consideration to be paid by Bannix at $<span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferred1_pn6n6_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--BannixMember_z7ZvjnvG7NXk" title="Business combination consideration paid">850 </span>million and, in turn, the consideration in the PPA to be paid to Tokenize is $<span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember_z8DygQ5H5xI5" title="Business combination consideration paid">42.5</span> million. If the final purchase price is less than $<span id="xdx_903_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn6n6_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember_z4w7Jh1dDU4k" title="Business combination purchase price">30</span> million, Tokenize has the option to cancel the PPA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance therewith, Bannix agrees to pay, issue and deliver to Tokenize, $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_za4y3EUq7hcd" title="Number of shares issued, value">42,500,000</span> in series A preferred stock to Tokenize, which such terms will be more fully set forth in the Series A Preferred Stock Certificate of Designation to be filed with the Secretary of State of the State of prior to the Closing Date. The Series A Preferred Stock will have stated value of face value of $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYJoi1Cx7Bn1" title="Preferred stock, par value">1,000</span> per share and is convertible, at the option of Tokenize, into shares of common stock of Bannix at 5% discount to the VWAP during the 20 trading days prior to conversion, and in any event not less than $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zhhDoQGRbvsc" title="Share price">1.00</span>. The Series A Preferred Stock will not have voting rights and will be entitled to dividends only in the event of liquidation. The Series A Preferred Stock will have a <span id="xdx_904_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zZZDZ1S1WtQ1" title="Beneficial ownership limitation">4.99</span>% beneficial ownership limitation. Series A Preferred Stock and the shares of common stock issuable upon conversion of the Series A Preferred Stock (the “Conversion Shares”) shall be subject to a lock-up beginning on the Closing Date and ending on the earliest of (i) the six (6) months after such date, (ii) a Change in Control, or (iii) written consent of Purchaser (the “Seller Lockup Period”)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 18, 2023, Bannix and Tokenize entered into Amendment No. 1 to the PPA. Per the amendment, Bannix and Tokenize agreed that the shares of common stock to be issued upon conversion of the Series A Preferred Stock will not exceed 19.99% of the aggregate number of shares of common stock issued and outstanding as of the closing of Bannix’s acquisition of EVIE (such maximum number of shares, the “<span style="text-decoration: underline">Exchange Cap</span>”) unless Bannix’s stockholders have approved the issuance of shares of common stock upon conversion of the Series A Preferred Stock pursuant to the PPA in excess of the Exchange Cap in accordance with the applicable rules of the market or exchange on which Bannix’s shares of common stock trade.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838">On March 11, 2024, Bannix sent EVIE and the shareholder of EVIE a notice providing that the BCA has been terminated (“BNIX EVIE Termination Letter”). As the PPA was contingent upon Bannix closing the acquisition of the EVIE and due to the BNIX EVIE Termination Letter, on March 19, 2024 Bannix and Tokenize agreed to terminate the PPA which was consented to by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Effective as of March 19, 2024, Tokeniz, entered into a Patent Purchase Agreement with VisionWave Technologies Inc. (“VisionWave”) pursuant to which VisionWave agreed to acquire from Tokenize the entire right, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and in motion objects (“VisionWave PPA”). </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838">The Purchase Price for the asset is $<span id="xdx_90B_ecustom--PurchasePrice_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--VisionWaveMember_zAIFCeEhs4i2" title="Purchase price">30,000,000</span> (the “Purchase Price”), which VisionWave will pay with shares of common stock, $0.0001 par value per share (the “Common Stock”). The Parties agree that the final Purchase Price may be adjusted and will be governed by a valuation report issued by a professional third party (“Valuation”). If the final Purchase Price per the Valuation is less than $<span id="xdx_90D_ecustom--PurchasePrice_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--TokenizeMember_zoOXemGgnm1i" title="Purchase price">30,000,000</span>, Tokenize has the option to cancel this Agreement. In accordance therewith, VisionWave agreed to issue and deliver to Tokenize, 1,000 shares of Common Stock (the “Shares”) representing 50% of VisionWave’s issued and outstanding shares of Common Stock, where the remainder of the 50% of VisionWave’s issued and outstanding shares of Common Stock are owned by a corporation controlled by Anat Attia. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Service Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 24, 2023 the Company entered into service agreement with Pacific Capital Markets LLC, where <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230223__20230224__dei--LegalEntityAxis__custom--PacificCaptitalMarketsLLCMember__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z0nhLQkpxdu" title="Number of shares issued, shares">100,000,000</span> Shares issued to it for certain for service agreement between Pacific Capital Markets LLC. and the Company. The value of the shares of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230223__20230224__dei--LegalEntityAxis__custom--PacificCaptitalMarketsLLCMember__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zXP3u9Bj0G29" title="Number of shares issued, value">80,000</span> was determined based on the FV of the Company’s common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Representation Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 17, 2023, Tokenize, which is <span id="xdx_90A_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20230817__srt--OwnershipAxis__custom--TokenizeMember_zFT30qPjYlik" title="Ownership percentage">50</span>% owned of the Company, which provided its consent, entered into a Representation Agreement (the ‘RA’) with IDL Concepts, LLC (the ‘Agent’) , to represent Tokenize in a potential purchase transaction facilitated by the Agent transferring all of Tokenize’s right, title, and interest in certain Assigned Patent Rights, as defined in the RA, free and clear of any restrictions, liens, claims, and encumbrances, and may include rights to technology and software developed by Tokenize. Tokenize owns certain provisional patent applications, patent applications, patents, and/or related foreign patents and applications, and wishes potentially to sell all right, title, and interest in such patents and applications and the causes of action to sue for infringement thereof and other enforcement rights. Tokenize will pay Agent a commission of 20% of any proceeds of any closed transaction under this RA, including all cash, equity payments and any other form of consideration upon a sale, or any monetization activity under the RA. The RA carved out certain intellectual properties held by Tokenize that Tokenize is in active negotiation with third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4	GTCH	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	-316911353	usd
CY2023Q4	GTCH	Working Capital Deficits WorkingCapitalDeficits	31620271	usd
CY2023	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	0	usd
CY2022	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	90000	usd

Files In Submission

Name	View Source	Status
0001731122-24-000657-index-headers.html	Edgar Link	pending
0001731122-24-000657-index.html	Edgar Link	pending
0001731122-24-000657.txt	Edgar Link	pending
0001731122-24-000657-xbrl.zip	Edgar Link	pending
e5600_10k.htm	Edgar Link	pending
e5600_ex31-1.htm	Edgar Link	pending
e5600_ex32-1.htm	Edgar Link	pending
e5600_ex4-18.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gtch-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
gtch-20231231_cal.xml	Edgar Link	unprocessable
gtch-20231231_def.xml	Edgar Link	unprocessable
gtch-20231231_lab.xml	Edgar Link	unprocessable
gtch-20231231_pre.xml	Edgar Link	unprocessable
e5600_10k_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTCH
GBT Technologies Inc. Stock $gtch

2024 Q2 Form 10-K Financial Statement

#000173112224000657 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH GBT Technologies Inc. Stock $gtch

2024 Q2 Form 10-K Financial Statement

#000173112224000657 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH
GBT Technologies Inc. Stock $gtch